<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Concept へのコメント</title>
	<atom:link href="https://numero.jp/concept/feed/" rel="self" type="application/rss+xml" />
	<link>https://numero.jp</link>
	<description>クリエイションが詰まったインターナショナル・モード誌『Numero TOKYO』のWEBサイト</description>
	<lastBuildDate>金, 17 4月 2026 12:00:25 +0900</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>USP36 NF31, 2013: U. S. Pharmacopoeia National Formulary - United States Pharmacopeial Convention free downloads より</title>
		<link>https://numero.jp/concept/#comment-113</link>
		<dc:creator>USP36 NF31, 2013: U. S. Pharmacopoeia National Formulary - United States Pharmacopeial Convention free downloads</dc:creator>
		<pubDate>Tue, 02 Jun 2015 21:46:05 +0000</pubDate>
		<guid isPermaLink="false">https://numero.jp/?page_id=285#comment-113</guid>
		<description>&lt;strong&gt;USP36 NF31, 2013: U. S. Pharmacopoeia National Formulary&lt;/strong&gt;

NO RETURNS accepted due to the specialized subject-matter and high cost of this product.MINT CONDITION (opened, not used)You can obtain more information</description>
		<content:encoded><![CDATA[<p><strong>USP36 NF31, 2013: U. S. Pharmacopoeia National Formulary</strong></p>
<p>NO RETURNS accepted due to the specialized subject-matter and high cost of this product.MINT CONDITION (opened, not used)You can obtain more information</p>
]]></content:encoded>
	</item>
</channel>
</rss>
